ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED FROM PREGNANT WOMEN.
Group B streptococcus (GBS) or Streptococcus agalactiae can colonize the gastrointestinal and genitourinary tracts and has been considered one of the most important risk factors for the development of neonatal disease. The present study evaluated the antimicrobial susceptibility of GBS isolates from pregnant women who were attended at a public health service in Northern Paraná, Brazil.
A descriptive analytical cross-sectional study was performed with 544 pregnant women, at ≥ 35 weeks of gestation. One hundred and thirty-six GBS isolates from pregnant women were tested for antimicrobial susceptibility.
All of the GBS isolates showed susceptibility to the drug that is most frequently used for intrapartum prophylaxis: penicillin. Resistance to clindamycin and erythromycin was detected, thus decreasing the options of prophylaxis in women who are allergic to penicillin.
Additional studies should be conducted to increase the knowledge of GBS sensitivity profile to antimicrobials in other health centers.
State University of Maringá, Postgraduate Program in Health Sciences Maringá, Paraná, Brazil. E-mails: simonecastanho@uenp.edu.br; mdbcarvalho@gmail.com; smpelloso@gmail.com or smpelloso@uem.br.
Simone Cristina Castanho Sabaini de
SC
Melo
State University of Maringá, Department of Clinical Analysis and Biomedicine. Maringá, Paraná, Brazil. E-mails: nathally_lyllii@hotmail.com; ma_piassoliv@outlook.com; regianebertin@gmail.com; rfressatticardoso@gmail.com or rfcardoso@uem.br; rafpadua@uem.br.
Nathally Claudiane de Souza
NC
Santos
State University of Maringá, Department of Clinical Analysis and Biomedicine. Maringá, Paraná, Brazil. E-mails: nathally_lyllii@hotmail.com; ma_piassoliv@outlook.com; regianebertin@gmail.com; rfressatticardoso@gmail.com or rfcardoso@uem.br; rafpadua@uem.br.
Marcia de
M
Oliveira
State University of Maringá, Department of Clinical Analysis and Biomedicine. Maringá, Paraná, Brazil. E-mails: nathally_lyllii@hotmail.com; ma_piassoliv@outlook.com; regianebertin@gmail.com; rfressatticardoso@gmail.com or rfcardoso@uem.br; rafpadua@uem.br.
Regiane Bertin de Lima
RB
Scodro
State University of Maringá, Department of Clinical Analysis and Biomedicine. Maringá, Paraná, Brazil. E-mails: nathally_lyllii@hotmail.com; ma_piassoliv@outlook.com; regianebertin@gmail.com; rfressatticardoso@gmail.com or rfcardoso@uem.br; rafpadua@uem.br.
Rosilene Fressatti
RF
Cardoso
State University of Maringá, Department of Clinical Analysis and Biomedicine. Maringá, Paraná, Brazil. E-mails: nathally_lyllii@hotmail.com; ma_piassoliv@outlook.com; regianebertin@gmail.com; rfressatticardoso@gmail.com or rfcardoso@uem.br; rafpadua@uem.br.
Rúbia Andreia Falleiros
RA
Pádua
State University of Northern Paraná, Nursing Sector. Bandeirantes, Paraná, Brazil. E-mails: flavia@uenp.edu.br; alinebalandis@uenp.edu.br.
Flavia Teixeira Ribeiro
FT
Silva
State University of Northern Paraná, Nursing Sector. Bandeirantes, Paraná, Brazil. E-mails: flavia@uenp.edu.br; alinebalandis@uenp.edu.br.
Aline Balandis
AB
Costa
State University of Maringá, Postgraduate Program in Health Sciences Maringá, Paraná, Brazil. E-mails: simonecastanho@uenp.edu.br; mdbcarvalho@gmail.com; smpelloso@gmail.com or smpelloso@uem.br.
Maria Dalva de Barros
MD
Carvalho
State University of Maringá, Postgraduate Program in Health Sciences Maringá, Paraná, Brazil. E-mails: simonecastanho@uenp.edu.br; mdbcarvalho@gmail.com; smpelloso@gmail.com or smpelloso@uem.br.
Sandra Marisa
SM
Pelloso
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002353:Carrier State / Q000382:microbiology; D003430:Cross-Sectional Studies; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology*; D013290:Streptococcal Infections / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000187:drug effects* / Q000302:isolation & purification; D014621:Vagina / Q000382:microbiology
D000900:Anti-Bacterial Agents